On June 21, 2021, PMG Pharmascience Co., Ltd. (KOSDAQ:A073570) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,995 KRW | -0.33% | -0.33% | -14.18% |
Mar. 20 | JW (Cayman) Therapeutics Shrinks Loss in Fiscal 2023 | MT |
Mar. 18 | JW Holdings Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
132,000 KRW | +2.96% | +0.84% | 2.53B | ||
8,100 KRW | +7.28% | +9.31% | 2.88B | ||
5,060 KRW | +0.60% | -2.69% | 133M | ||
4,205 KRW | +0.12% | -2.77% | 283M | ||
1st Jan change | Capi. | |
---|---|---|
-14.18% | 159M | |
+19.62% | 42.97B | |
+24.52% | 22.49B | |
+20.29% | 14.93B | |
+7.48% | 13.14B | |
+42.51% | 11.67B | |
-8.84% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.54B |
- Stock Market
- Equities
- A096760 Stock
- News JW Holdings Corporation
- PMG Pharmascience Co., Ltd. announced that it has received KRW 15 billion in funding from Eugene Investment & Securities Co.,Ltd., JJ Assets Co., Ltd., Mirae Asset Securities Co., Ltd., JW Holdings Corporation, Kiwoom Securities Co., Ltd.